HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$6.53
Day range
$6.07 - $6.60
Year range
$5.92 - $18.65
Market cap
112.89M USD
Avg Volume
80.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.40M | 7.19% |
Net income | -4.17M | -3.01% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.46M | 25.83% |
Total assets | 19.71M | 21.63% |
Total liabilities | 5.69M | 44.69% |
Total equity | 14.02M | — |
Shares outstanding | 18.36M | — |
Price to book | 8.59 | — |
Return on assets | -56.51% | — |
Return on capital | -83.82% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.17M | -3.01% |
Cash from operations | -4.36M | 8.77% |
Cash from investing | — | — |
Cash from financing | 4.70M | 1,763.49% |
Net change in cash | 338.00K | 107.47% |
Free cash flow | -2.93M | 21.67% |
About
Founded
2020
Headquarters
Website
Employees
13